|
1
|
Shen CY, Jiang JG, Yang L, Wang DW and Zhu
W: Anti-ageing active ingredients from herbs and nutraceuticals
used in traditional Chinese medicine: Pharmacological mechanisms
and implications for drug discovery. Br J Pharmacol. 174:1395–1425.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang S, Lu J, Yan J and Zhang H: Research
progress of preparation technology and pharmacological effect of
cycloastragenol. Chin J New Drugs. 16:1872–1875. 2016.
|
|
3
|
Ip FC, Ng YP, An HJ, Dai Y, Pang HH, Hu
YQ, Chin AC, Harley CB, Wong YH and Ip NY: Cycloastragenol is a
potent telomerase activator in neuronal cells: Implications for
depression management. Neurosignals. 22:52–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salvador L, Singaravelu G, Harley CB, Flom
P, Suram A and Raffaele JM: A natural product telomerase activator
lengthens telomeres in humans: A randomized, double blind and
placebo controlled study. Rejuvenation Res. 19:478–484. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hemann MT, Strong MA, Hao LY and Greider
CW: The shortest telomere, not average telomere length, is critical
for cell viability and chromosome stability. Cell. 107:67–77. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernardes de Jesus B, Schneeberger K, Vera
E, Tejera A, Harley CB and Blasco MA: The telomerase activator
TA-65 elongates short telomeres and increases health span of
adult/old mice without increasing cancer incidence. Aging Cell.
10:604–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Saux CJ, Davy P, Brampton C, Ahuja SS,
Fauce S, Shivshankar P, Nguyen H, Ramaseshan M, Tressler R, Pirot
Z, et al: A novel telomerase activator suppresses lung damage in a
murine model of idiopathic pulmonary fibrosis. PLoS One.
8:e584232013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yung LY, Lam WS, Ho MK, Hu Y, Ip FC, Pang
H, Chin AC, Harley CB, Ip NY and Wong YH: Astragaloside IV and
cycloastragenol stimulate the phosphorylation of extracellular
signal-regulated protein kinase in multiple cell types. Planta Med.
78:115–121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J: Astragaloside IV and cycloastragenol
attenuate osteoblastic injury and aging elicited by oxidative
stress. 2017.
|
|
10
|
Bektas A, Schurman SH, Sen R and Ferrucci
L: Human T cell immunosenescence and inflammation in aging. J
Leukoc Biol. 102:977–988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Molgora B, Bateman R, Sweeney G, Finger D,
Dimler T, Effros RB and Valenzuela HF: Functional assessment of
pharmacological telomerase activators in human T cells. Cells.
2:57–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verotta L, Guerrini M, El-Sebakhy NA,
Assad AM, Toaima SM, Radwan MM, Luo YD and Pezzuto JM: Cycloartane
and oleanane saponins from egyptian Astragalus spp. as modulators
of lymphocyte proliferation. Planta Med. 68:986–994. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fauce SR, Jamieson BD, Chin AC, Mitsuyasu
RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB and Effros RB:
Telomerase-based pharmacologic enhancement of antiviral function of
human CD8+ T lymphocytes. J Immunol. 181:7400–7406. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sevimli-Gur C, Onbasilar I, Atilla P, Genç
R, Cakar N, Deliloğlu-Gürhan I and Bedir E: In vitro growth
stimulatory and in vivo wound healing studies on cycloartane-type
saponins of Astragalus genus. J Ethnopharmacol. 134:844–850. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng JJ, Li SP, Zhao FY, Tong Y, Mu DZ and
Qu Y: Effect of telomerase activation on biological behavior of
neural stem cells in hypoxic-ischemic rats. Zhongguo Dang Dai Er Ke
Za Zhi. 19:229–36. 2017.(In Chinese). PubMed/NCBI
|
|
16
|
Yi Z and Gao W: Protective effects of
cycloastragenol on focal cerebral ischemia reperfusion injury in
rats. Journa Cheng Medical Collage. 1–188. 2015.
|
|
17
|
Gao W: Pfect of cycloastragenol on
neuronal apoptosis and TERT expression after cerebral ischemia
reperfusion in rats. Chin J Pathophysiology. 10:18582015.
|
|
18
|
Reichert S, Bize P, Arrive M, Zahn S,
Massemin S and Criscuolo F: Experimental increase in telomere
length leads to faster feather regeneration. Exp Gerontol.
52:36–38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S, Zhai C, Liu Q, Wang X, Ren Z,
Zhang Y, Zhang Y, Wu Q, Sun S, Li S and Qiao Y: Cycloastragenol, a
triterpene aglycone derived from Radix astragali, suppresses the
accumulation of cytoplasmic lipid droplet in 3T3-L1 adipocytes.
Biochem Biophysical Res Commun. 450:306–311. 2014. View Article : Google Scholar
|
|
20
|
Gu M, Zhang S, Zhao Y, Huang J, Wang Y, Li
Y, Fan S, Yang L, Ji G, Tong Q and Huang C: Cycloastragenol
improves hepatic steatosis by activating farnesoid X receptor
signalling. Pharmacol Res. 121:22–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao Y, Li W, Wei L, Liu X, Li Z and He W:
Anti-aging effect of cyclogreitol on D-galactose induced aging
mice. Chin J Exp Tradit Med Formulae. 1–211. 2012.
|
|
22
|
Richter T and von Zglinicki T: A
continuous correlation between oxidative stress and telomere
shortening in fibroblasts. Exp Gerontol. 42:1039–1042. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Y, Li Q, Zhao W, Li J, Sun Y, Liu K,
Liu B and Zhang N: Astragaloside IV and cycloastragenol are equally
effective in inhibition of endoplasmic reticulum stress-associated
TXNIP/NLRP3 inflammasome activation in the endothelium. J
Ethnopharmacol. 169:210–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun C, Jiang M, Zhang L, Yang J, Zhang G,
Du B, Ren Y, Li X and Yao J: Cycloastragenol mediates activation
and proliferation suppression in concanavalin A-induced mouse
lymphocyte pan-activation model. Immunopharmacol Immunotoxicol.
39:131–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harley CB, Liu W, Blasco M, Vera E,
Andrews WH, Briggs LA and Raffaele JM: A natural product telomerase
activator as part of a health maintenance program. Rejuvenation
Res. 14:45–56. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harley CB, Liu W, Flom PL and Raffaele JM:
A natural product telomerase activator as part of a health
maintenance program: metabolic and cardiovascular response.
Rejuvenation Res. 16:386–395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dow CT and Harley CB: Evaluation of an
oral telomerase activator for early age-related macular
degeneration-a pilot study. Clin Ophthalmol. 10:243–249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aschacher T, Wolf B, Enzmann F, Kienzl P,
Messner B, Sampl S, Svoboda M, Mechtcheriakova D, Holzmann K and
Bergmann M: LINE-1 induces hTERT and ensures telomere maintenance
in tumour cell lines. Oncogene. 35:94–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szabo NJ: Dietary safety of
cycloastragenol from Astragalus spp: Subchronic toxicity and
genotoxicity studies. Food Chem Toxicol. 64:322–334. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ran R, Zhang C, Li R, Chen B, Zhang W,
Zhao Z, Fu Z, Du Z, Du X, Yang X and Fang Z: Evaluation and
comparison of the inhibition effect of astragaloside IV and
aglycone cycloastragenol on various UDP-Glucuronosyltransferase
(UGT) isoforms. Molecules. 21:E16162016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
T.A.: Sciences®:
TA-65® Receives Generally Recognized as Safe Status.
https://www.tasciences.com/ta-65-receives-generally-recognized-safe-status/November
19–2014
|
|
32
|
Shay JW and Bacchetti S: A survey of
telomerase activity in human cancer. Eur J Cancer. 33:787–791.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu J, Lee S, Ho MK, Hu Y, Pang H, Ip FC,
Chin AC, Harley CB, Ip NY and Wong YH: In vitro intestinal
absorption and first-pass intestinal and hepatic metabolism of
cycloastragenol, a potent small molecule telomerase activator. Drug
Metab Pharmacokinet. 25:477–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X: In vitro and in vivo metabolism
research of astragaloside iv and cycloastragenol (unpublished PhD
thesis). Beijing University of Chinese Medicine. 2013, PubMed/NCBI
|
|
35
|
Wei B, Ye J, Bi B, Sun G, Yang X and Zhang
Y: Effect of continuous intragastric administration of
cycloastragenol on liver p450 enzymes in rats. Chin J New Drugs.
1–479. 2014.
|
